Larrayoz MJ - Search Results

1

Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death.

Fresquet V, Garcia-Barchino MJ, Larrayoz M, Celay J, Vicente C, Fernandez-Galilea M, Larrayoz MJ, Calasanz MJ, Panizo C, Junza A, Han J, Prior C, Fortes P, Pio R, Oyarzabal J, Martinez-Baztan A, Paiva B, Moreno-Aliaga MJ, Odero MD, Agirre X, Yanes O, Prosper F, Martinez-Climent JA. Fresquet V, et al. Among authors: larrayoz m, larrayoz mj. Cancer Discov. 2021 May;11(5):1268-1285. doi: 10.1158/2159-8290.CD-20-1065. Epub 2020 Dec 18. Cancer Discov. 2021. PMID: 33355179

2

Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients.

Agirre X, Vizmanos JL, Calasanz MJ, García-Delgado M, Larráyoz MJ, Novo FJ. Agirre X, et al. Among authors: larrayoz mj. Oncogene. 2003 Feb 20;22(7):1070-2. doi: 10.1038/sj.onc.1206236. Oncogene. 2003. PMID: 12592393

3

t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia.

Vizmanos JL, Larráyoz MJ, Lahortiga I, Floristán F, Alvarez C, Odero MD, Novo FJ, Calasanz MJ. Vizmanos JL, et al. Among authors: larrayoz mj. Genes Chromosomes Cancer. 2003 Apr;36(4):402-5. doi: 10.1002/gcc.10174. Genes Chromosomes Cancer. 2003. PMID: 12619164 Free article.

4

NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15).

Lahortiga I, Vizmanos JL, Agirre X, Vázquez I, Cigudosa JC, Larrayoz MJ, Sala F, Gorosquieta A, Perez-Equiza K, Calasanz MJ, Odero MD. Lahortiga I, et al. Among authors: larrayoz mj. Cancer Res. 2003 Jun 15;63(12):3079-83. Cancer Res. 2003. PMID: 12810632 Free article.

5

TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia.

Agirre X, Novo FJ, Calasanz MJ, Larráyoz MJ, Lahortiga I, Valgañón M, García-Delgado M, Vizmanos JL. Agirre X, et al. Among authors: larrayoz mj. Mol Carcinog. 2003 Dec;38(4):201-8. doi: 10.1002/mc.10159. Mol Carcinog. 2003. PMID: 14639659

6

Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response.

Agirre X, Fontalba A, Andreu EJ, Odero MD, Larráyoz MJ, Montiel C, Calasanz MJ, Fernández-Luna JL, Prósper F. Agirre X, et al. Among authors: larrayoz mj. Haematologica. 2003 Dec;88(12):1425-6. Haematologica. 2003. PMID: 14687999 No abstract available.

7

Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.

Lahortiga I, Agirre X, Belloni E, Vázquez I, Larrayoz MJ, Gasparini P, Lo Coco F, Pelicci PG, Calasanz MJ, Odero MD. Lahortiga I, et al. Among authors: larrayoz mj. Oncogene. 2004 Jan 8;23(1):311-6. doi: 10.1038/sj.onc.1206923. Oncogene. 2004. PMID: 14712237 Free article.

8

NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorder.

Vizmanos JL, Novo FJ, Román JP, Baxter EJ, Lahortiga I, Larráyoz MJ, Odero MD, Giraldo P, Calasanz MJ, Cross NC. Vizmanos JL, et al. Among authors: larrayoz mj. Cancer Res. 2004 Apr 15;64(8):2673-6. doi: 10.1158/0008-5472.can-04-0144. Cancer Res. 2004. PMID: 15087377 Free article.

9

Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements.

Lahortiga I, Vázquez I, Agirre X, Larrayoz MJ, Vizmanos JL, Gozzetti A, Calasanz MJ, Odero MD. Lahortiga I, et al. Among authors: larrayoz mj. Genes Chromosomes Cancer. 2004 Jul;40(3):179-89. doi: 10.1002/gcc.20033. Genes Chromosomes Cancer. 2004. PMID: 15138998 Free article.

10

Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion.

Vizmanos JL, Larráyoz MJ, Vázquez I, Odero MD, Hernández R, Lahortiga I, Novo FJ, Ardanaz MT, Calasanz MJ. Vizmanos JL, et al. Among authors: larrayoz mj. Cancer Genet Cytogenet. 2004 Jul 15;152(2):177-8. doi: 10.1016/j.cancergencyto.2003.12.002. Cancer Genet Cytogenet. 2004. PMID: 15262444 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters